BioSpace News Archive

BioCapital

The AMA Alliance Presents “The Opioid Epidemic: Empowering Community Action,” A Collaboration With ITN Productions

Opioid misuse has claimed far too many lives in the United States.

January 31, 2019
·
2 min read
Pharm Country

Life Time Chappaqua Announces February 8 Opening for Members at 5:00 am

Exclusive VIP event set for 6:00 p.m. Feb. 7; Nearly 200 new jobs created to inspire healthy, happy lives for all ages at new athletic destination

January 31, 2019
·
2 min read
Policy

BIO Statement on New Proposal for Lowering Out-of-Pocket Costs for Medicines

BIO’s President and CEO Jim Greenwood issued the following statement today after the Trump administration released a proposed rule that would alter safe harbor policies under the federal anti-kickback statute:

January 31, 2019
·
1 min read
BioCapital

Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress

United Therapeutics Corporation today announced that key data from the FREEDOM-EV study of Orenitram® extended-release tablets were shared during an oral presentation at the Pulmonary Vascular Research Institute Annual World Congress on Pulmonary Vascular Disease in Barcelona, Spain.

January 31, 2019
·
10 min read
G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies

G+FLAS Life Sciences, Inc., a CRISPR/Cas genome editing company in South Korea, announced that they licensed two patents regarding Non-GMO ways of plant genome engineering.

January 31, 2019
·
1 min read
Job Trends

Axxess Home Health Software Meets CMS Requirement on Advanced Directives Information

A Statement from Andrew Olowu, Axxess Chief Technology Officer:

January 31, 2019
·
1 min read
Business

McKesson Reports Fiscal 2019 Third-Quarter Results

Revenues of $56.2 billion for the third quarter, up 5% year over year.

January 31, 2019
·
36 min read
Genetown

Leap Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced an underwritten public offering of its common stock and warrants to purchase common stock.

January 31, 2019
·
5 min read
Job Trends

Galaxy CCRO, Inc. Launches with A License Agreement with Proteome Sciences PLC, London, U K

Galaxy, a clinical contract research organization, is pleased to announce the launch of its company through a cornerstone product built on its license agreement with Proteome Sciences and its point of care license of Intellectual Property.

January 31, 2019
·
2 min read
Sartorius Joins the Community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Sartorius, a leading international partner of biopharmaceutical research and the industry, is pleased to announce that it has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals headquartered in Newark, Delaware, USA.

January 31, 2019
·
4 min read